Novel Immunotherapeutic Strategies of Gastric Cancer Treatment

Gastric cancer (GC) is the fourth most common cancer and the second most frequent cause of cancer-related deaths, accounting for 10.4% of cancer deaths worldwide. Despite the improvements, estimated cure rates for patients with advanced stages remain poor, and in the metastatic setting, chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Amedei, Amedeo, Benagiano, Marisa, della Bella, Chiara, Niccolai, Elena, D'Elios, Mario M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255571/
https://www.ncbi.nlm.nih.gov/pubmed/22253528
http://dx.doi.org/10.1155/2011/437348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255571/
https://www.ncbi.nlm.nih.gov/pubmed/22253528
http://dx.doi.org/10.1155/2011/437348

Ejemplares similares